Showing results (1501-1510 of 1,598) with videos related to
Sort By:
Pageof 160
Cancer Journal (Sudbury, Mass.)|September 20, 2017
Epigenetic Regulation of Dendritic Cell Development and FunctionYuanyuan Tian, Lijun Meng, Yi ZhangCancer Journal (Sudbury, Mass.)|January 24, 2023
Impact of Precision Medicine in Oncology: Immuno-oncologyElizabeth I Buchbinder, F Stephen HodiCancer Journal (Sudbury, Mass.)|January 24, 2023
Emerging Challenges to Cellular Therapy of CancerPremal D Lulla, Malcolm BrennerCancer Journal (Sudbury, Mass.)|January 24, 2023
Transcription Factors and Cancer: Approaches to TargetingJamie V Shiah, Daniel E Johnson, Jennifer R GrandisCancer Journal (Sudbury, Mass.)|September 18, 2020
Targeting Metabolic Pathways in Kidney Cancer: Rationale and Therapeutic OpportunitiesChristian R Hoerner, Susanna Y Miao, James J Hsieh, et al.Cancer Journal (Sudbury, Mass.)|September 18, 2020
The Reintroduction of Radiotherapy Into the Integrated Management of Kidney CancerMichael Dohopolski, Raquibul Hannan, Zabi Wardak, et al.Cancer Journal (Sudbury, Mass.)|December 10, 2020
What Is the Standard First-Line Treatment for Advanced Non-Small Cell Lung Cancer?Biagio Ricciuti, Mark M AwadCancer Journal (Sudbury, Mass.)|May 20, 2022
Individual Benefits and Risks of Intravaginal Estrogen and Systemic Testosterone in the Management of Women in the Menopause, With a Discussion of Any Associated Risks for Cancer DevelopmentAbbie J Laing, Louise Newson, James A SimonCancer Journal (Sudbury, Mass.)|October 15, 2009
Response rates: a valuable signal of promising activity?Xavier Pivot, Antoine Thierry-Vuillemin, Cristian Villanueva, et al.Cancer Journal (Sudbury, Mass.)|October 15, 2009
Progression-free survival is simply a measure of a drug's effect while administered and is not a surrogate for overall survivalJulia Wilkerson, Tito FojoPageof 160